6-35737325-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_145028.5(ARMC12):c.217G>A(p.Glu73Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000322 in 1,614,204 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_145028.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARMC12 | ENST00000288065.6 | c.217G>A | p.Glu73Lys | missense_variant | 1/6 | 1 | ENSP00000288065.2 | |||
ARMC12 | ENST00000373866.4 | c.163+54G>A | intron_variant | 3 | NM_001286574.2 | ENSP00000362973.3 | ||||
ARMC12 | ENST00000373869.7 | c.163+54G>A | intron_variant | 2 | ENSP00000362976.3 | |||||
ARMC12 | ENST00000471400.1 | n.163+54G>A | intron_variant | 3 | ENSP00000418825.1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152228Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000637 AC: 16AN: 251248Hom.: 1 AF XY: 0.0000663 AC XY: 9AN XY: 135826
GnomAD4 exome AF: 0.0000301 AC: 44AN: 1461858Hom.: 1 Cov.: 32 AF XY: 0.0000316 AC XY: 23AN XY: 727234
GnomAD4 genome AF: 0.0000525 AC: 8AN: 152346Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74502
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 04, 2024 | The c.217G>A (p.E73K) alteration is located in exon 1 (coding exon 1) of the ARMC12 gene. This alteration results from a G to A substitution at nucleotide position 217, causing the glutamic acid (E) at amino acid position 73 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at